Description: Sevikar HCT 40/5/25 mg Tablets are a combination medication used to manage hypertension (high blood pressure). The tablets combine three active ingredients: olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide. This combination works synergistically to lower blood pressure more effectively than using a single medication. Sevikar HCT not only helps in reducing high blood pressure but also decreases the risk of cardiovascular events such as stroke and heart attack.
Ingredients:
- Active Ingredients:
- Olmesartan Medoxomil 40 mg
- Amlodipine Besylate 5 mg
- Hydrochlorothiazide 25 mg
- Other Ingredients: [List any inactive ingredients if known]
Usage Instructions:
- Dosage: Take one tablet orally once daily, or as prescribed by your healthcare provider.
- Frequency: Once daily.
- Special Considerations: Swallow the tablet whole with a glass of water. Can be taken with or without food. Try to take it at the same time each day. Do not stop taking the medication without consulting your healthcare provider.
Benefits:
- Effectively lowers high blood pressure.
- Reduces the risk of cardiovascular events like heart attack and stroke.
- Combines three antihypertensive agents for comprehensive blood pressure control.
- Convenient once-daily dosage improves patient compliance.
Precautions:
- Contraindications: Not to be used in individuals allergic to olmesartan, amlodipine, hydrochlorothiazide, or any other ingredients in the product.
- Side Effects: Possible side effects include dizziness, headache, swelling in the ankles or feet, and gastrointestinal disturbances. Severe side effects may include allergic reactions, severe hypotension, and electrolyte imbalances. Seek medical attention if these occur.
- Consult with your doctor if you have a history of kidney disease, liver disease, or heart disease before using this medication.
Storage Instructions:
- Store at room temperature (20-25°C).
- Keep in a dry place away from moisture and direct sunlight.
- Keep out of reach of children.
Manufacturer: Saja Pharmaceuticals
